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方法：1、体外细胞实验，分离培养出生 24小时 SD大鼠软骨细胞，用 IL-1β
（20ng/ml）处理 36小时，建立大鼠 OA 软骨细胞模型，IL-1Ra（40ng/ml）培养
36小时：（1）提取总 RNA及蛋白，经 real-time PCR、western blotting检测




的核蛋白进行免疫共沉淀法处理，western blotting检测核蛋白中 LC3B 的乙酰化
水平；（4）Tat-Beclin1 (10μM)处理 8小时，western blotting检测 CollagenⅡ、
Aggrecan、Beclin1、LC3B的蛋白水平，常规免疫荧光及 JEM2100-HC电镜超薄
切片制作处理后，观察细胞内自噬泡形态。
2、体内实验，“ACLT+MMx”(anterior cruciate ligament transection with partial





切片分别行 HE染色、番红 O-固绿及免疫组化处理（分别结合 CollagenⅡ、
Aggrecan、Beclin1 及 LC3B抗体），BX-51OLYMPUS显微镜观察拍片。

















量明显多于未处理组；（3）western blotting实验显示，IL-1Ra 处理组 P-Akt/Akt、
P-mTOR/mTOR、P-ULK1/ULK1、P-NF-κB/p65/NF-κB/p65 比值显著高于未处理
的大鼠 OA 软骨细胞；同时，IL-1Ra 处理降低细胞核内 LC3B的乙酰化水平；（4）
western blotting实验显示，自噬增强剂 Tat-Beclin1促进 SD大鼠模拟 OA软骨细
胞的基质合成，同时亦能显著提高 IL-1Ra 对 SD大鼠模拟 OA 软骨细胞基质合成




IL-1Ra 与 Tat-Beclin1 联合用药组效果最佳。（2）组化结果显示，与对照组比较，




其中调节自噬的相关通路包括 Akt/mTOR/ULK1 与 Akt/NF-κB/p65；并与细胞核
内 LC3B 乙酰化水平相关；自噬增强剂 Tat-Beclin1 能有效提高 IL-1Ra 对 OA 软
骨细胞的保护作用。

















Introduction: The inflammatory cytokines ,especially IL-1β ,play important
role in the development and progression of osteoarthritis (OA). Targeting
inflammatory cytokine is an efficient treatment for OA. In this study, we aim to
investigate the protective mechanism of IL-1 receptor antagonist(IL-1Ra) on OA
chondrocytes, and to explore a method to promote IL-1Ra chondroprotection in OA
rat model in vitro and vivo.
Methods: In vitro: Chondrocytes were isolated from knee cartilage of neonatal
male Sprague–Dawley rats (within 24 hours after birth).These cells were suspended in
DMEM/F12 containing 10% fetal bovine serum (FBS), then cells were cultured with
IL-1β (20ng/ml) stimulation for 36 hours,followed with the treatment of IL-1Ra
（40ng/ml） for 36 hours: (1) total mRNA and proteins of Collagen II, Aggrecan,
Beclin1, and LC3B from chondrocytes were detected with real-time PCR and western
blotting. Akt, P-Akt, mTOR, P-mTOR, ULK1, P-ULK1, NF-κB/p65, and
P-NF-κB/p65 were detected with western blotting as well. Meanwhile， autophagic
vacuoles were detected with immunofluorescence and transmission electron
microscopy. (2) The protein level of LC3B in nucleus and cytoplasm was detected
with western blotting analysis. (3) The acetylation level of LC3B protein in nucleus
were detected with immunoprecipitation.(4) After cells were cultured with
Tat-Beclin1(10µM) for 8 hours，total proteins of Collagen II, Aggrecan, Beclin1, and
LC3B were detected with western blotting. Meanwhile, autophagic vacuoles were
detected with immunofluorescence and transmission electron microscopy.
In vivo: 45 Sprague–Dawley rats (about 4 - 5 weeks old male,120g) were used in
inducing with anterior cruciate ligament transection combined with resection of
medial menisci (ACLT + MMx). (1)Samples were divided into 7 groups: normal,
sham, OA, OA + saline, OA+IL-1Ra, OA+Tat-Beclin1, and OA+IL-1Ra+Tat-Beclin1
group. After surgery, these ingredients were injected into the knee joints （ twice a















joints were acquired for H.E. staining, Safarinin-O staining, and
immunohistochemistrical analysis(combining with CollagenII,Aggrecan,Beclin1 and
LC3B antibody respectively ), followed with morphological observation.
Results: In vitro: (1)The results of real-time PCR and western blotting showed
that IL-1Ra increased the mRNA and protein levels of CollagenII,Aggrecan,Beclin1
and LC3B in IL-1β-stimulated rat OA chondrocytes. (2)Meanwhile, the number of
autophagic vacuoles was increased by the treatment of IL-1Ra. (3)The ratio of
P-Akt/Akt, P-mTOR/mTOR, P-ULK1/ULK, and P-NF-κB/p65/NF-κB/p65 were
increased by the treatment of IL-1Ra. Meanwhile, the acetylation level of LC3B in
nuclear was decreased. (4) Tat-Beclin1 not only could up-regulate the CollagenII and
Aggrecan protein levels, but also could enhance the protective effect of IL-1Ra on OA
chondrocyte(*P<0.05,**P<0.01, ***P<0.001,****p < 0.0001 ).
In vivo: (1)The intra-articular injections with IL-1Ra, Tat-Beclin1, and
IL-1Ra+Tat-Beclin1 could ameliorate cartilage impairment in rat OA models,
compared with control group.Among them, the effect of IL-1Ra+TAT-beclina on
cartilage is the best one. (2) The levels of CollagenII, Aggrecan,Beclin1, and LC3B
were more increased in IL-1Ra, Tat-Beclin1, and IL-1Ra+Tat-Beclin1 groups,
compared with control group. Among them, the effect of IL-1Ra+TAT-beclina on
these protein expressions is the best one(*P<0.05,**P<0.01, ***P<0.001,****p <
0.0001 )。
Conclusion: In this study, IL-1Ra could promote the synthesis of extracellular
matrix(CollagenII and Aggrecan), as well as the increased autophagy (Beclin1 and
LC3B) in IL-1β-stimulated rat OA chondrocytes and OA rat model. Akt/NF-κB/p65,
Akt/mTOR/ULK1, and the deacetylation of LC3B were involved in regulating
autophagy related to IL-1Ra. Tat-Beclin1 could improve the protective effect of
IL-1Ra in early OAmodel.
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(extracellularmatrix, ECM)。而膝关节部位 OA 最显著的特征为软骨细胞的凋亡和
ECM的降解[3]。软骨细胞作为软骨组织中唯一的细胞类型，主要作用为促进自身
代谢，维持 ECM 稳态以及分泌细胞因子等[4]。在 OA 发生发展中，软骨细胞凋
亡起到关键作用[5]。软骨胞外基质主要成分为Ⅱ型胶原(Collagen Ⅱ)和蛋白聚糖




metalloproteinases, MMPs)，蛋白聚糖酶 (a disintegrin and metalloproteinase with




























Raynauld 等人的实验结果显示，对 355 位膝关节 OA 患者随机分组，分别给予
Licofelone（200mg，一天两次）及萘普生（500mg,一天两次），6、12、24 个
月后进行核磁及 X光拍片检查，发现 Licofelone 作为 5-脂氧合酶及环加氧酶抑制
剂能显著改善软骨体积的丢失，减轻 OA 患者的症状[11]。Brandt KD等研究提示，
强力霉素与安慰剂相比，能降低患者关节空间宽度指数[12]。同时，在靶向治疗方






或 AMG 108（人单克隆抗体，能竞争性结合白介素 1受体 IL-1R1）皮下（SC；
75 毫克或 300 毫克）或静脉注射（IV；100 毫克或 300 毫克），共 12 周，每 4




















1.2 IL-1β及白介素受体拮抗剂在 OA 领域的研究进展
1.2.1 IL-1β在骨性关节炎内的病理生理机制
研究表明，炎症因子的分泌与 OA 相关，尤其前炎性因子是 OA 发展进程中
重要的调节因子，其与关节软骨退化有关。白细胞介素 IL-1β（Interleukin-1β，
IL-1β）作为主要的前炎症因子，由软骨细胞、单核细胞、成骨细胞及滑膜组织




IL-1β抑制 CollagenⅡ及蛋白聚糖 Aggrecan 的表达[21]，刺激金属蛋白酶（起到降
解软骨作用）MMP-1，MMP-3，MMP-13[22]及Ⅰ型血小板结合蛋白基序的解聚蛋
白样金属蛋白酶 ADAMTS 的表达[23],诱使软骨细胞胞外基质降解。而 IL-1β的促
炎作用和分解代谢作用由多种信号通路调控，包括核因子κB、c-Jun氨基端激酶
(the c-Jun N-terminal kinase)、Wnt–βcatenin 通路以及 ERK 信号通路 [24]。其中
NF-κBp65 在 OA滑膜炎中富集，参与了软骨细胞与胞外基质的破坏[25]。
1.2.2 白介素受体拮抗剂在 OA 领域的研究进展
软骨细胞及滑膜成纤维细胞中会产生一种天然的 IL-1β活性抑制剂——白介
素受体拮抗剂（IL-1 receptor antagonist， IL-1Ra），它能与 IL-1β竞争性结合到
IL-1RⅠ及 IL-1RⅡ上，且不产生信号[26]。
研究结果显示关节腔内注射 IL-1Ra，可部分缓解 OA软骨损伤。例如，在大













































































PI3K 磷脂酰肌醇-3-羟激酶，可使肌醇环第 3 位羟基磷酸化，按其结构分为Ⅰ型、
Ⅱ型和Ⅲ型。其中Ⅰ型 PI3K 激活可抑制细胞自噬。它的第二信使 PIP3和 PDK1




蛋白激酶 B(protein kinase B, PKB/Akt)是一种丝氨酸/苏氨酸激酶，在各种组
织内广泛表达。Akt包括 Akt1/PKBα、Akt2/PKBβ和 Akt/PKBγ 3种亚型，由 3个
不同基因编码，但它们的蛋白质高级结构基本相同，都包括一个 N端 PH结构域
(plecstrin homology domain，PHdomain)、一个 C 端调节区(Akt 丝氨酸残基磷酸
化调节区，Ser473/Akt1)和激酶催化区(Thr308/Akt1)[41]。其主要通过磷酯酰肌醇-3
激酶激活发生作用。Akt 通过直接磷酸化多种下游信号分子如 Bad、NF-κB 和
mTOR等参与调控细胞内多种生命活动。比如，Akt通过磷酸化作用激活 IKB激
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